REGULATORY

Pipe Damage Causes Water Leak at Sawai Plant after Quake: MHLW

July 30, 2026
Japanese Health Minister Kenichiro Ueno
Japanese Health Minister Kenichiro Ueno

A water leak caused by damaged piping has been reported at one of Sawai Pharmaceutical's factories in Fukuoka Prefecture following a massive earthquake that hit southwestern Japan on July 28. However, the incident is unlikely to affect product supplies.

The Ministry of Health, Labor and Welfare (MHLW) said on July 29 that the leak at Sawai’s Daini Kyushu Factory is expected to take several days to repair, but the generic maker has sufficient inventory to maintain supplies. Other manufacturers have also reported damage, but none has reported disruptions to product supply.

At a meeting of the ministry’s disaster response headquarters the same day, Health Minister Kenichiro Ueno said three MHLW officials had been dispatched to the Kumamoto prefectural government to support disaster response efforts. He instructed ministry staff to continue gathering information and provide all possible assistance to affected residents.

Related Article

REGULATORY

By Takashi Ebisawa

Japan should fundamentally overhaul its cost-effectiveness assessment (CEA) scheme while putting a hold on CEA-based price adjustments, a new ruling…

By Koji Shimomura

Global drug makers are forging ahead with therapies targeting lipoprotein(a), or Lp(a), a promising new approach to reducing cardiovascular risks.…

Japanese Prime Minister Sanae Takaichi said on October 14 that the government will consider the necessary measures for the FY2027…

By Takashi Ebisawa

Eli Lilly’s breast cancer drug Imulrio (imlunestrant) is finally joining Japan’s NHI price list on October 14, nearly 300 days…

By Philip Carrigan

The Wednesday TableShe had been on virtual calls since eight in the morning. The screen glowed. Her eyes burned. Plugged into Teams across time zones, she was digitally connected yet entirely isolated from the reality of Japan’s pharma market.She needed…

Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…

Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…

The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…

Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…

Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…